Current treatment of low grade gliomas

Por van den Bent, Martin J., Snijders, Tom J., Bromberg, Jacoline E. C.
Publicado em 2012

A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes

Por de Jongste, Adriaan H., van Gelder, Teun, Bromberg, Jacoline E., de Graaf, Marieke T., Gratama, Jan W., Schreurs, Marco W., Hooijkaas, Herbert, Sillevis Smitt, Peter A.
Publicado no Neuro Oncol (2015)

Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation – an International Primary Central Nervous System Lymphoma Study Group project

Por Bromberg, Jacoline E., Doorduijn, Jeanette K., Illerhaus, Gerald, Jahnke, Kristoph, Korfel, Agniezka, Fischer, Lars, Fritsch, Kristina, Kuittinen, Outti, Issa, Samar, van Montfort, Cees, van den Bent, Martin J.
Publicado em 2013

Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study

Por Taal, Walter, Segers-van Rijn, Joyce M. W., Kros, Johan M., van Heuvel, Irene, van der Rijt, Carin C. D., Bromberg, Jacoline E., Sillevis Smitt, Peter A. E., van den Bent, Martin J.
Publicado em 2012

Withdrawal of antiepileptic drugs in glioma patients after long-term seizure freedom: design of a prospective observational study

Por Koekkoek, Johan A F, Kerkhof, Melissa, Dirven, Linda, Heimans, Jan J, Postma, Tjeerd J, Vos, Maaike J, Bromberg, Jacoline E C, van den Bent, Martin J, Reijneveld, Jaap C, Taphoorn, Martin J B
Publicado no BMC Neurol (2014)

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma

Por Wilson, Wyndham H., Bromberg, Jacoline E.C., Stetler-Stevenson, Maryalice, Steinberg, Seth M., Martin-Martin, Lourdes, Muñiz, Carmen, Sancho, Juan Manuel, Caballero, Maria Dolores, Davidis, Marjan A., Brooimans, Rik A., Sanchez-Gonzalez, Blanca, Salar, Antonio, González-Barca, Eva, Ribera, Jose Maria, Shovlin, Margaret, Filie, Armando, Dunleavy, Kieron, Mehrling, Thomas, Spina, Michele, Orfao, Alberto
Publicado em 2014

First-line temozolomide chemotherapy in progressive low-grade astrocytomas after radiotherapy: molecular characteristics in relation to response

Por Taal, Walter, Dubbink, Hendrikus J., Zonnenberg, Chris B.L., Zonnenberg, Bernard A., Postma, Tjeerd J., Gijtenbeek, Johanna M.M., Boogerd, Willem, Groenendijk, Floris H., Kros, Johan M., Kouwenhoven, Mathilde C.M., van Marion, Ronald, van Heuvel, Irene, van der Holt, Bronno, Bromberg, Jacoline E.C., Sillevis Smitt, Peter A.E., Dinjens, Winand N.M., van den Bent, Martin J.
Publicado em 2011

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma: A randomized phase III Intergroup study by EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033)

Por Baumert, Brigitta G., Hegi, Monika E., van den Bent, Martin J., von Deimling, Andreas, Gorlia, Thierry, Hoang-Xuan, Khê, Brandes, Alba A., Kantor, Guy, Taphoorn, Martin J.B., Hassel, Mohamed Ben, Hartmann, Christian, Ryan, Gail, Capper, David, Kros, Johan M., Kurscheid, Sebastian, Wick, Wolfgang, Enting, Roelien, Reni, Michele, Thiessen, Brian, Dhermain, Frederic, Bromberg, Jacoline E., Feuvret, Loic, Reijneveld, Jaap C., Chinot, Olivier, Gijtenbeek, Johanna M. M., Rossiter, John P., Dif, Nicolas, Balana, Carmen, Bravo-Marques, Jose, Clement, Paul M., Marosi, Christine, Tzuk-Shina, Tzahala, Nordal, Robert A., Rees, Jeremy, Lacombe, Denis, Mason, Warren P., Stupp, Roger
Publicado no Lancet Oncol (2016)